Navigation Links
CardioDx Completes Validation Study of First-Of-Its-Kind Genomic Test for Coronary Artery Disease
Date:8/25/2009

PALO ALTO, Calif., Aug. 25 /PRNewswire/ -- CardioDx, a cardiovascular genomic diagnostics company, announced today that the company has successfully completed its multicenter validation study for Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(1) coronary artery disease (CAD) in patients with stable chest pain. The company expects to present results of the study by the end of 2009, and will publish the results in 2010.

Following completion of the validation study, CardioDx has made Corus CAD available in nine states initially, with broader availability expected in 2010. The test is now available in Kentucky, Maryland, Illinois, Washington, Wisconsin, Minnesota, North Carolina, Texas and Arizona. Patient samples are processed in Palo Alto at CardioDx's CLIA-certified laboratory.

"Completing the validation study for Corus CAD marks a major milestone for CardioDx," said David Levison, chief executive officer of CardioDx. "Our focus now turns to further developing the clinical and economic evidence needed to increase patient access to the unique benefits of Corus CAD."

Currently, the presence of obstructive CAD in patients with stable chest pain is most often evaluated through functional and/or anatomical assessment of the heart and its vessels, including stress echocardiography, myocardial perfusion imaging, and computed tomography angiography. However, despite advances in imaging technology, these techniques can be subjective and challenging for cardiologists, because of variation in presenting symptoms and each patient's unique disease characteristics. Corus CAD provides unique genomic information about an individual's disease processes at the molecular and cellular levels. When this information is combined with standard clinical assessments, physicians obtain a more complete picture of their patient's disease and can bett
'/>"/>

SOURCE CardioDx
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Warner Chilcott plc (Nasdaq: ... Warner Chilcott Corporation (the "Company") has commenced a ... to the conditions set forth in the Company,s ... December 15, 2009 (the "Offer to Purchase"), for ... subordinated notes due 2015 (the "Notes"). ,, The ...
(Date:12/15/2009)... -- Immucor, Inc. (Nasdaq: BLUD ), a global ... transfusion industry, today announced that it will release its ... 2010 after the market close. The Company will host ... 8:30 a.m. (Eastern Time) to discuss the results. ... conference call by dialing 1-888-324-9321 (Passcode: BLUD). Investors can ...
(Date:12/15/2009)... INCLINE VILLAGE, Nev., Dec. 15 PDL BioPharma, ... it has paid the December 15, 2009 special dividend ... shares of PDL as of December 1, 2009. ... ended December 31, 2009 total $2.67 per share. ... regarding the federal tax characteristics of the Company,s 2009 ...
Breaking Medicine Technology:Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6PDL BioPharma Completes December 15 Special Dividend Payment 2ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 1ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 2ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 3ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 4ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 5ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 6ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 7ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 8ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 9ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 10Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 1Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 2Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 3Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 4Brain Scans Could Help Spot Schizophrenia Earlier 56674 1Brain Scans Could Help Spot Schizophrenia Earlier 56674 2
... /PRNewswire-FirstCall/ --,Alfacell Corporation's ONCONASE (ranpirnase) has shown ... antibody conjugates for cancer therapy,according to the ... , In a chapter of the text ... research indicating that the,specificity and potency of ...
... Levels in Two Most Common Mutations, CRANBURY, ... a biopharmaceutical company developing small,molecule, orally-administered pharmacological ... human genetic diseases, announced today,that it will ... (isofagomine tartrate, AT2101) for Gaucher disease at,the ...
Other Medicine Technology:Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 2Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 3Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 4Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 2Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 3
(Date:12/15/2009)... SUMMARY: The U.S. Senate ... and Affordable Care Act that would have helped ... the safe and legal importation of lower priced ... AARP and sponsored by Senators Dorgan, Snowe, McCain, ... helped to bring down the skyrocketing costs of ...
(Date:12/15/2009)... coal for lying about taxes in the healthcare bill ... has earned a place under the "Naughty" column on Americans ... after being caught telling a brazen lie on the floor ... bill would not raise taxes. ,, Speaking on the ... " I have also heard it ...
(Date:12/15/2009)... High levels of leptin associated with lower dementia risk, ... High blood levels of leptin, a hormone that regulates ... , "Hopefully, in 10 or 15 years this may ... reduce the risk of Alzheimer,s disease," said senior study ... at Boston University School of Medicine. "Or it may ...
(Date:12/15/2009)... education program will train advocates to be leaders ... Project developed with support from experts in online ... ,, WASHINGTON, Dec. 15 ... are accepting applications for the first-ever "Malaria Griots" ... and educate participants to become leaders in the ...
(Date:12/15/2009)... Dec. 15 The following are the ... for the criminal division, at the Medicare Fraud ... Sebelius. And thank you for the enormous effort ... initiative. ,, Together, our Departments have and ... ,, We,ve made tremendous progress in fighting Medicare ...
Breaking Medicine News(10 mins):Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3
... largest rollouts of Digital Dictation technology within the NHS produces significant ... ... 2009 -- BigHand has today announced that Sheffield Teaching Hospitals NHS ... over 1000 users spanning 5 hospitals on 2 campuses in one ...
... Dr. Elizabeth M. Trinidad, a fellowship trained pediatric neurosurgeon, has joined Neurological ... the New York Tristate area. Dr. Trinidad specialized in the treatment ... spine and is also a Lieutenant Colonel with the United States ... ...
... , Tuesday, January 13, 2009 , 10:00 a.m. Eastern Standard Time ... Queens , NY , Locations of ... by the National Institutes of Health: What: A media telephone ... National Children,s Study. The largest child health study in the ...
... ignored their cost saving suggestionsHARRISBURG, Pa., Jan. 6 ... closing the state,s budget shortfall, SEIU Local 668, the ... Pennsylvania, said they have identified millions of dollars that ... cancel contracts with private contractors for work that can ...
... FARMINGDALE, N.Y., Jan. 6 Dieters craving a ... pounds can now find a refreshing option at ... Integrated Beverage Group, Ltd. (IBG). The company, a ... announced major new relationships with leading distributors, retailers ...
... technologies can create environments that require very little physical ... Nintendo,s Wii Fit can help promote physical rather than ... think there is a great potential to develop ways ... professor and head of the department of kinesiology at ...
Other Medicine News:Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 3Health News:Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D. 2Health News:Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D. 3Health News:Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D. 4Health News:Telebriefing: National Children's Study Recruitment Begins 2Health News:State Human Services Union Identifies Ways to Save Millions of Tax Dollars 2Health News:Skinny Dippers(TM), First Zero-Calorie Frozen Dessert, Earns Widespread Retail, Online Distribution 2Health News:Wii Fit a promising tool for all ages 2Health News:Wii Fit a promising tool for all ages 3
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
... Nile Virus IgG DxSelect is intended,for ... Nile virus in human,serum. In conjunction ... Virus,IgM Capture DxSelect, the test is ... meningioencephalitis, as an aid in the,presumptive ...
... PachPen uses state-of-the-art waveform analysis ... at a 65MHz rate to ... stores and averages nine measurements ... pen fits comfortably into the ...
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
Medicine Products: